Stockreport

Immunic appoints Michael Panzara as CMO ahead of pivotal MS drug readout [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF Immunic Inc (NASDAQ:IMUX, FRA:10VA) has named Michael A. Panzara as Chief Medical Officer, bringing aboard a veteran neurologist with more than 25 years of drug develop [Read more]